ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study of MDX-010 in Stage IV Breast Cancer

This study has been completed.
Study NCT00083278.   Last updated on February 27, 2007.   Information provided by Medarex
Please refer to this study by its ClinicalTrials.gov identifier: NCT00083278


Locations
United States, California
Sharp Clinical Oncology Research    
      San Diego, California, United States, 92123
United States, Indiana
Medical Arts Building    
      Jeffersonville, Indiana, United States, 47130
Section of Hematology/Oncology, Indiana Cancer Pavilion    
      Indianapolis, Indiana, United States, 46202-5289
Indiana University, Clarian Health Partners    
      Indianapolis, Indiana, United States, 46202
Wishard Health Services    
      Indianapolis, Indiana, United States, 46202-2859
United States, Kansas
Kansas City Oncology and Hematology Group    
      Overland Park, Kansas, United States, 66210
Kansas City Oncology and Hematology Group    
      Kansas City, Kansas, United States, 66112
United States, Kentucky
Norton Healthcare Inc, Loiusville Oncology Clinical Research Program    
      Louisville, Kentucky, United States, 40202
Suburban Medical Plaza II    
      Louisville, Kentucky, United States, 40207
Audubon Oncology/Hematology    
      Louisville, Kentucky, United States, 40217
LaGrange    
      LaGrange, Kentucky, United States, 40031
United States, Missouri
Kansas City Oncology and Hematology Group    
      Kansas City, Missouri, United States, 64131
Kansas City Oncology and Hematology Group    
      Lee's Summit, Missouri, United States, 64064
United States, Texas
Arlington Cancer Center    
      Arlington, Texas, United States, 76012

Sponsors and Collaborators
Medarex





Links to all studies - primarily for crawlers